Gottardis MM - Search Results

1

9-cis-Retinoic acid suppresses mammary tumorigenesis in C3(1)-simian virus 40 T antigen-transgenic mice.

Wu K, Kim HT, Rodriquez JL, Munoz-Medellin D, Mohsin SK, Hilsenbeck SG, Lamph WW, Gottardis MM, Shirley MA, Kuhn JG, Green JE, Brown PH. Wu K, et al. Among authors: gottardis mm. Clin Cancer Res. 2000 Sep;6(9):3696-704. Clin Cancer Res. 2000. PMID: 10999763

2

Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma.

Bischoff ED, Gottardis MM, Moon TE, Heyman RA, Lamph WW. Bischoff ED, et al. Among authors: gottardis mm. Cancer Res. 1998 Feb 1;58(3):479-84. Cancer Res. 1998. PMID: 9458093

3

The efficacy of 9-cis retinoic acid in experimental models of cancer.

Gottardis MM, Lamph WW, Shalinsky DR, Wellstein A, Heyman RA. Gottardis MM, et al. Breast Cancer Res Treat. 1996;38(1):85-96. doi: 10.1007/BF01803787. Breast Cancer Res Treat. 1996. PMID: 8825126 Review.

4

Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand.

Gottardis MM, Bischoff ED, Shirley MA, Wagoner MA, Lamph WW, Heyman RA. Gottardis MM, et al. Cancer Res. 1996 Dec 15;56(24):5566-70. Cancer Res. 1996. PMID: 8971154

5

High IGF-IR activity in triple-negative breast cancer cell lines and tumorgrafts correlates with sensitivity to anti-IGF-IR therapy.

Litzenburger BC, Creighton CJ, Tsimelzon A, Chan BT, Hilsenbeck SG, Wang T, Carboni JM, Gottardis MM, Huang F, Chang JC, Lewis MT, Rimawi MF, Lee AV. Litzenburger BC, et al. Among authors: gottardis mm. Clin Cancer Res. 2011 Apr 15;17(8):2314-27. doi: 10.1158/1078-0432.CCR-10-1903. Epub 2010 Dec 22. Clin Cancer Res. 2011. PMID: 21177763 Free PMC article.

6

Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.

Shalinsky DR, Bischoff ED, Gregory ML, Gottardis MM, Hayes JS, Lamph WW, Heyman RA, Shirley MA, Cooke TA, Davies PJ, et al. Shalinsky DR, et al. Among authors: gottardis mm. Cancer Res. 1995 Jul 15;55(14):3183-91. Cancer Res. 1995. PMID: 7541715

7

Efficacy of LGD1069 (Targretin), a retinoid X receptor-selective ligand, for treatment of uterine leiomyoma.

Gamage SD, Bischoff ED, Burroughs KD, Lamph WW, Gottardis MM, Walker CL, Fuchs-Young R. Gamage SD, et al. Among authors: gottardis mm. J Pharmacol Exp Ther. 2000 Nov;295(2):677-81. J Pharmacol Exp Ther. 2000. PMID: 11046105

8

BMS-536924 reverses IGF-IR-induced transformation of mammary epithelial cells and causes growth inhibition and polarization of MCF7 cells.

Litzenburger BC, Kim HJ, Kuiatse I, Carboni JM, Attar RM, Gottardis MM, Fairchild CR, Lee AV. Litzenburger BC, et al. Among authors: gottardis mm. Clin Cancer Res. 2009 Jan 1;15(1):226-37. doi: 10.1158/1078-0432.CCR-08-0801. Clin Cancer Res. 2009. PMID: 19118050 Free PMC article.

9

Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine leiomyoma.

Houston KD, Copland JA, Broaddus RR, Gottardis MM, Fischer SM, Walker CL. Houston KD, et al. Among authors: gottardis mm. Cancer Res. 2003 Mar 15;63(6):1221-7. Cancer Res. 2003. PMID: 12649180

10

Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor.

Carboni JM, Lee AV, Hadsell DL, Rowley BR, Lee FY, Bol DK, Camuso AE, Gottardis M, Greer AF, Ho CP, Hurlburt W, Li A, Saulnier M, Velaparthi U, Wang C, Wen ML, Westhouse RA, Wittman M, Zimmermann K, Rupnow BA, Wong TW. Carboni JM, et al. Cancer Res. 2005 May 1;65(9):3781-7. doi: 10.1158/0008-5472.CAN-04-4602. Cancer Res. 2005. PMID: 15867374

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters